These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9863041

  • 1. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets.
    Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR.
    J Control Release; 1999 Jan 04; 57(1):75-85. PubMed ID: 9863041
    [Abstract] [Full Text] [Related]

  • 2. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS, Saha RN.
    Drug Deliv; 2008 Jan 04; 15(3):159-68. PubMed ID: 18379928
    [Abstract] [Full Text] [Related]

  • 3. Formulation and evaluation of diclofenac sodium using hydrophilic matrices.
    Rao YM, Veni JK, Jayasagar G.
    Drug Dev Ind Pharm; 2001 Sep 04; 27(8):759-66. PubMed ID: 11699827
    [Abstract] [Full Text] [Related]

  • 4. Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets.
    Rahmouni M, Lenaerts V, Massuelle D, Doelker E, Johnson M, Leroux JC.
    Pharm Dev Technol; 2003 Sep 04; 8(4):335-48. PubMed ID: 14601958
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME.
    Drug Dev Ind Pharm; 2013 Nov 04; 39(11):1651-62. PubMed ID: 23094867
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release.
    Al-Hanbali OA, Hamed R, Arafat M, Bakkour Y, Al-Matubsi H, Mansour R, Al-Bataineh Y, Aldhoun M, Sarfraz M, Dardas AKY.
    Pak J Pharm Sci; 2018 Jan 04; 31(1(Suppl.)):345-351. PubMed ID: 29386164
    [Abstract] [Full Text] [Related]

  • 9. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM, Alzoubi NM.
    Pharmazie; 2014 Feb 04; 69(2):96-103. PubMed ID: 24640597
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of physicochemical properties of hydroxypropyl methylcellulose (HPMC) type 2208 and their influence on prolonged drug release from matrix tablets.
    Devjak Novak S, Šporar E, Baumgartner S, Vrečer F.
    J Pharm Biomed Anal; 2012 Jul 04; 66():136-43. PubMed ID: 22510313
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium.
    Kumar SM, Chandrasekar MJ, Gopinath R, Srinivasan R, Nanjan MJ, Suresh B.
    Drug Deliv; 2007 Mar 04; 14(3):163-9. PubMed ID: 17454036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac.
    Rahmouni M, Chouinard F, Nekka F, Lenaerts V, Leroux JC.
    Eur J Pharm Biopharm; 2001 May 04; 51(3):191-8. PubMed ID: 11343882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The influence of moisture content on the consolidation properties of hydroxypropylmethylcellulose K4M (HPMC 2208).
    Nokhodchi A, Ford JL, Rowe PH, Rubinstein MH.
    J Pharm Pharmacol; 1996 Nov 04; 48(11):1116-21. PubMed ID: 8961157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.